Skip to content

Clinical trials

Recruiting Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Recruiting Country / region: Netherlands Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20141
20162
20173
20182
20195
20201
20214
20226
202311
202414
202516
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
Erasmus Medical Center5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Eli Lilly and Company3
GlaxoSmithKline3
Leiden University Medical Center3
Radboud University Medical Center3
UMC Utrecht3
AbbVie2
Academisch Ziekenhuis Maastricht2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms75
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms8
Breast Neoplasms7
Colorectal Neoplasms6
Esophageal Neoplasms5
Neoplasms by Site5
Colonic Neoplasms4
Endometrial Neoplasms4
Head and Neck Neoplasms4

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.